Dose-response modeling of continuous endpoints

Toxicological Sciences

Volumn 66, Issue 2, 2002, Pages 298-312

  Slob, Wout ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Benchmark dose; Continuous endpoints; Critical effect size; Dose response modeling; Probabilistic assessment factor

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MALE; MATHEMATICAL COMPUTING; MAXIMUM LIKELIHOOD METHOD; METHODOLOGY; MODEL; NONHUMAN; OUTCOMES RESEARCH; POPULATION RESEARCH; PROBABILITY; QUALITY CONTROL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STATISTICAL PARAMETERS; TOXICOLOGY;

ANIMALS; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; FEMALE; MALE; MODELS, STATISTICAL; NONLINEAR DYNAMICS; TOXICOLOGY;

ANIMALIA;

EID: 0036206395     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/66.2.298     Document Type: Article

References (21)

1. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels
2. Evaluation of the applicability of the Benchmark approach to existing toxicological data. Framework: Chemical compounds in the working place
3. Noncancer risk assessment: A probabilistic alternative to current practice
4. A new method for determining allowable daily intakes
5. Calculation of benchmark doses from continuous data
6. Dose-response assessment for developmental toxicity. I. Characterization of database and determination of no observed adverse effect levels
7. Risk assessment for neurotoxic effects
8. Distributions of individual susceptibility among humans for toxic effects. How much protection does the traditional tenfold factor provide for what fraction of which kinds of chemicals and effects?
9. Conversion factors estimating indicative chronic no-observed-adverse-effect levels from short-term toxicity data
10. Characterizing dose-response I: Critical assessment of the benchmark dose concept
11. Developmental toxicity of butyl benzyl phthalate in the rat using a multiple dose study design
12. Evaluation of the uncertainty factor for subchronic-to-chronic extrapolation: Statistical analysis of toxicity data
13. FDA's priority-based assessment of food additives. II. General toxicity parameters
14. Strategies in applying statistics in ecological research
15. Thresholds in toxicology and risk assessment
16. A probabilistic approach for deriving acceptable human intake limits and human health risks from toxicological studies: General framework
17. A probabilistic framework for the reference dose
18. Assessment factors for human health risk assessment A discussion paper
19. Relationship between short- and long-term feeding studies in designing an effective toxicity test
20. The benchmark approach applied to a 28-day toxicity study with Rhodorsil Silane in rats. The impact of increasing the number of dose groups